About

Bio

Background and Format: Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal's broad coverage includes all areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are of relevance to human health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of medical science. All original research articles will be considered that are within the journal's scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: Research articles Preliminary communications Short communications Methodologies Trial design articles Trial results (including early-phase and negative studies) Reviews Perspectives Commentaries Audience and Readership: Scientists in the biotechnology field Deadline: Average lead time to online publication: 14-16 weeks Circulation: A circulation figure is not available. Distribution: The journal is distributed free of charge online Editorial contacts: The Editorial Board members can be viewed here  Manuscript submission: Instructions for authors and editorial guidelines can be viewed here Ad rates: For more information on advertising see here  Other Information: Future Science OA provides readers the rigorous publication standards and article production quality they expect from the Future Science Group, with all articles subject to review by a minimum of three independent experts. The journal follows a gold open access model, publishing all articles under the Creative Commons CC-BY license to allow maximum dissemination. Authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.

Email

email@cision.one

Website

site@cision.one

Social media

linkedin x facebook reddit

Location

United Kingdom

Frequency

upgrade

Circulation

upgrade

Sectors

Biotechnology


Is this you? We'd love to hear from you, contact our journalist team.
Contact us to unlock the full profile

Most recent articles by Future Science OA

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consectetur adipiscing elit

Article description

Lorem ipsum dolor sit amet
Contact us to explore recent articles

Explore outlets similar to Future Science OA

  • Scientific American
    Scientific American

    Established in 1845, Scientific American remains the oldest continuously-published magazine in the United States. Redesigned in October 2010, the publication covers the most important and exciting research in science, health, technology, the environment, and society, exploring important ideas often months and years before other media recognizes their importance. The magazine publishes 15 foreign language editions, and regular sections include Forum, which provides a platform for external experts to comment on science policy; Science Agenda, where editors can discuss different science issues; and Insights, which profiles a scientist or researcher and analyzes their contribution to society. Other sections include Anti Gravity and Skeptic. Regular columns include The Science of Health and TechnoFiles. Publicists should feel free to pitch anytime, although they should avoid pitching individual products or new company officer announcements. They should focus on science-based stories that are better told by a journalist than an expert.

    View
  • Popular Mechanics
    Popular Mechanics

    Published by Hearst and established in 1902, Popular Mechanics is designed to satisfy the reader's passion to know how and why things work. The publication covers how today's technologies affect the things readers are most interested in: their homes, consumer electronics, cars, science, computers, sports, and current events, and explains the way the world works in the 21st century. Editorial engages readers with breakthroughs on the latest advances in science and technology, and educates with informative how-to stories on digital technology, automotive, and the home. It also motivates minds to act with product reviews and comparisons on all of the latest equipment and products. Articles are broken into five departments: - Technology: covering the Internet, personal computers, computer games, and other consumer electronics - Automotive: featuring articles about new car models, motor sports, and automotive repair and maintenance - Science: covering general interest health, technology, and physical science topics - Home: offering home maintenance and renovation information - Outdoors: covering sports and outdoor recreation Other editorial sections include: - Technology Watch: a front-of-book section offering short news items on technology, aviation, environment, energy, computers, robotics, space, transportation, health, and military - Spy Report: comprehensive sneak peeks of cars and trucks coming out of the U.S., Europe, and Asia - Great Stuff: listing new home, automotive, recreation, consumer electronics, and fitness products - Time Machine: revisiting article topics from 90, 60, and 30 years ago

    View
  • MIT Technology Review
    MIT Technology Review

    Established in 1899 and written for venture capitalists and hi-tech executives as an informational source on innovative and improved technologies and their applications. Focuses on promoting the understanding of emerging technologies and their impact. Strives to promote the understanding of emerging technology and its impact on the world. Aims to promote the understanding of emerging technologies and to analyze their commercial, social and political impacts. Assists technology and business leaders including CXOs, entrepreneurs, researchers, venture capitalists and financiers as they drive the global economy.

    View
  • Endpoints News
    Endpoints News

    Endpoints News covers Biopharmaceutical industry. Offers data-driven news and analysis for industry professionals covering research and development. Content is a combination of originally produced and curated from around the web and is available in real-time and via a daily newsletter. This site is available via RSS (Really Simple Syndication).

    View
  • Nature Reviews Drug Discovery
    Nature Reviews Drug Discovery

    Impact Factor:22.66 (Source: Scimago Journal & Country Rank)Circulation: The figure is not currently disclosed.Aims of the journal:Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition it seeks to provide the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.Content: The journal covers the following subjects: Target discovery Rational drug design Combinatorial and parallel synthesis Medicinal chemistry Key compound classes Natural products High-throughput screening Novel therapeutic approaches to disease states Microarrays Bioinformatics and chemoinformatics Absorption, distribution, metabolism and elimination (ADME) Pharmacokinetics and pharmacodynamics Pharmacology Toxicology Pharmacogenomics and toxicogenomics Drug delivery Biopharmaceuticals Biotechnology Vaccines Clinical trial evaluation Regulatory issues PharmacoeconomicsEditorial contacts: See the list of editors here.The editorial office can be reached at naturereviews@nature.com.Manuscript submission:To be published in nature Reviews Drug Discovery a manuscript should meet the following criteria: Timely, accurate and balanced Important to scientists in the specific field Interesting and accessible to researchers in other areas of Drug DiscoverySubmit online at http://mts-nrdd.nature.com/cgi-bin/main.plex

    View
Use CisionOne to find more relevant outlets

Contact Future Science OA and get access to over 850K accurate, up-to-date media profiles.

Discover the stories that impact your brand. In realtime.

CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.